Published in Gastroenterology on October 01, 2002
Small bowel involvement in Crohn's disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysis. Gut (2005) 1.78
Clinical application of wireless capsule endoscopy in pediatric patients for suspected small bowel diseases. Eur J Pediatr (2006) 0.94
Metastatic carcinoid tumor discovered by capsule endoscopy and not detected by esophagogastroduodenoscopy. Dig Dis Sci (2004) 0.84
Comments regarding article comparing small bowel radiographs and video capsule endoscopy. Gastroenterology (2003) 0.78
Sedation With Propofol Has No Effect on Capsule Endoscopy Completion Rates: A Prospective Single-Center Study. Medicine (Baltimore) (2015) 0.75
Discussion on "cutting the cord" for capsule endoscopy. Gastroenterology (2003) 0.75
Reproducibility of wireless capsule endoscopy in the investigation of chronic obscure gastrointestinal bleeding. Can J Gastroenterol (2007) 0.75
A prospective trial comparing small bowel radiographs and video capsule endoscopy for suspected small bowel disease. Gastroenterology (2002) 7.97
Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med (2009) 10.91
Guideline for the management of ingested foreign bodies. Gastrointest Endosc (2002) 9.03
Quality indicators for colonoscopy. Am J Gastroenterol (2006) 6.51
Quality indicators for colonoscopy. Gastrointest Endosc (2014) 4.17
Quality indicators for colonoscopy. Gastrointest Endosc (2006) 3.83
EUS-guided sampling of suspected GI stromal tumors. Gastrointest Endosc (2009) 3.61
Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc (2007) 3.53
A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology (2004) 3.50
Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology (2011) 3.44
ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc (2006) 3.12
Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol (2002) 3.04
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc (2006) 2.63
Guidelines for antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc (2003) 2.60
Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology (2006) 2.46
ASGE guideline: The role of endoscopy in acute non-variceal upper-GI hemorrhage. Gastrointest Endosc (2004) 2.33
4-Liter split-dose polyethylene glycol is superior to other bowel preparations, based on systematic review and meta-analysis. Clin Gastroenterol Hepatol (2012) 2.30
ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc (2005) 2.11
Management of anticoagulation before and after gastrointestinal endoscopy. Am J Gastroenterol (2009) 2.08
Quality indicators for colonoscopy. Am J Gastroenterol (2014) 2.06
Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy. Gastrointest Endosc (2003) 2.04
ASGE Guideline: the role of endoscopy in the management of variceal hemorrhage, updated July 2005. Gastrointest Endosc (2005) 1.99
Urgent vs. elective endoscopy for acute non-variceal upper-GI bleeding: an effectiveness study. Gastrointest Endosc (2004) 1.96
Endoscopic evaluation of patients with dyspepsia: results from the national endoscopic data repository. Gastroenterology (2004) 1.88
Complications of ERCP. Gastrointest Endosc (2003) 1.84
Polypectomy rate is a valid quality measure for colonoscopy: results from a national endoscopy database. Gastrointest Endosc (2012) 1.83
Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology (2004) 1.82
Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials. Clin Gastroenterol Hepatol (2006) 1.75
A multicenter randomized comparison of the Endocapsule and the Pillcam SB. Gastrointest Endosc (2008) 1.74
ASGE guideline: The role of endoscopy in the diagnosis and the management of cystic lesions and inflammatory fluid collections of the pancreas. Gastrointest Endosc (2005) 1.74
Esophageal dilation. Gastrointest Endosc (2006) 1.68
Comparison of Transgastric NOTES and laparoscopic peritoneoscopy for detection of peritoneal metastases. Ann Surg (2009) 1.68
Complications of colonoscopy. Gastrointest Endosc (2003) 1.65
Assessment of the quality of colonoscopy reports: results from a multicenter consortium. Gastrointest Endosc (2009) 1.64
Yield of tissue sampling for subepithelial lesions evaluated by EUS: a comparison between forceps biopsies and endoscopic submucosal resection. Gastrointest Endosc (2006) 1.60
Guidelines for the use of deep sedation and anesthesia for GI endoscopy. Gastrointest Endosc (2002) 1.57
Obscure gastrointestinal bleeding. Gastrointest Endosc (2003) 1.56
Preparation of patients for GI endoscopy. Gastrointest Endosc (2003) 1.54
Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc (2002) 1.54
Can the clinical history distinguish between organic and functional dyspepsia? JAMA (2006) 1.51
Acute colonic pseudo-obstruction. Gastrointest Endosc (2002) 1.50
Interobserver agreement among endosonographers for the diagnosis of neoplastic versus non-neoplastic pancreatic cystic lesions. Gastrointest Endosc (2003) 1.49
Quality indicators for endoscopic retrograde cholangiopancreatography. Gastrointest Endosc (2006) 1.46
Quality indicators for endoscopic retrograde cholangiopancreatography. Am J Gastroenterol (2006) 1.42
ASGE Guideline: the role of endoscopy in the patient with lower-GI bleeding. Gastrointest Endosc (2005) 1.39
ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc (2006) 1.36
Yield of tissue sampling for submucosal lesions evaluated by EUS. Gastrointest Endosc (2003) 1.34
Polypectomy rate as a quality measure for colonoscopy. Gastrointest Endosc (2011) 1.32
ASGE guideline: complications of EUS. Gastrointest Endosc (2005) 1.32
GI stromal tumors. Gastrointest Endosc (2003) 1.30
Forty-eight-hour pH monitoring increases sensitivity in detecting abnormal esophageal acid exposure. J Gastrointest Surg (2005) 1.27
Intrapancreatic accessory spleen: mimic of pancreatic endocrine tumor diagnosed by endoscopic ultrasound-guided fine-needle aspiration biopsy. Diagn Cytopathol (2008) 1.26
Methods of granting hospital privileges to perform gastrointestinal endoscopy. Gastrointest Endosc (2002) 1.25
Complications of upper GI endoscopy. Gastrointest Endosc (2002) 1.24
Plastic versus self-expanding metallic stents for malignant hilar biliary obstruction: a prospective multicenter observational cohort study. J Clin Gastroenterol (2008) 1.24
ASGE guideline: the management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures. Gastrointest Endosc (2005) 1.23
Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases. Appl Immunohistochem Mol Morphol (2003) 1.18
ASGE Guideline: Guidelines for endoscopy in pregnant and lactating women. Gastrointest Endosc (2005) 1.13
ASGE guideline: the role of endoscopy in the diagnosis, staging, and management of colorectal cancer. Gastrointest Endosc (2005) 1.10
EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases. Gastrointest Endosc (2002) 1.10
Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer: a review. Gastrointest Endosc (2002) 1.09
The role of endoscopy in the evaluation and treatment of patients with pancreaticobiliary malignancy. Gastrointest Endosc (2003) 1.09
Medical decision analysis of chemoprevention against esophageal adenocarcinoma. Gastroenterology (2003) 1.08
EUS in pediatric patients. Gastrointest Endosc (2009) 1.07
AGA Institute technical review on the use of endoscopic therapy for gastroesophageal reflux disease. Gastroenterology (2006) 1.06
Quality indicators for esophagogastroduodenoscopy. Am J Gastroenterol (2006) 1.06
Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium. Dig Dis Sci (2003) 1.05
Quality indicators for esophagogastroduodenoscopy. Gastrointest Endosc (2006) 1.03
The quality of colonoscopy services--responsibilities of referring clinicians: a consensus statement of the Quality Assurance Task Group, National Colorectal Cancer Roundtable. J Gen Intern Med (2010) 1.02
A closer look at same-day bidirectional endoscopy. Gastrointest Endosc (2008) 1.02
Measurement of polypectomy rate by using administrative claims data with validation against the adenoma detection rate. Gastrointest Endosc (2012) 0.99
Bringing new endoscopic imaging technology into everyday practice: what is the role of professional GI societies? Polyp imaging as a template for moving endoscopic innovation forward to answer key clinical questions. Gastrointest Endosc (2009) 0.95
Open access endoscopy. Gastrointest Endosc (2002) 0.94
Quality indicators for endoscopic ultrasonography. Gastrointest Endosc (2006) 0.94
Quality indicators for endoscopic ultrasonography. Am J Gastroenterol (2006) 0.94
ASGE guideline: guidelines for credentialing and granting privileges for capsule endoscopy. Gastrointest Endosc (2005) 0.93
Endoscopic diagnosis of gastrointestinal stromal cell tumors. Curr Opin Gastroenterol (2007) 0.90
A comparison of EUS features between CD-117 positive GI stromal tumors and CD-117 negative GI spindle cell tumors. Gastrointest Endosc (2003) 0.89
The role of EUS for evaluation of mediastinal adenopathy. Gastrointest Endosc (2003) 0.87
Diagnostic ascertainment of suspicious pancreatic mass: a threshold analysis. Clin Gastroenterol Hepatol (2008) 0.86
Tissue sampling and analysis. Gastrointest Endosc (2003) 0.85
Gold standard medical therapy for glaucoma: defining the criteria identifying measures for an evidence-based analysis. Clin Ther (2004) 0.85
ASGE guideline: guideline on the use of endoscopy in the management of constipation. Gastrointest Endosc (2005) 0.84
Through-the-scope balloon dilation for endoscopic ultrasound staging of stenosing esophageal cancer. Dig Dis Sci (2007) 0.83
The ERCP quality network: a pilot study of benchmarking practice and performance. Am J Med Qual (2012) 0.82
Role of endoscopy in enteral feeding. Gastrointest Endosc (2002) 0.82
Endoscopic ultrasound in patients over 80 years old. Dig Dis Sci (2011) 0.81
Diagnostic yield of colonoscopy to evaluate melena after a nondiagnostic EGD. Gastrointest Endosc (2012) 0.80
The role of endoscopy in the assessment and treatment of esophageal cancer. Gastrointest Endosc (2003) 0.80
The emerging role of QSOX1 in cancer. Antioxid Redox Signal (2014) 0.79
Barrett's-related esophageal cancer: has the final hurdle been cleared, now paving the way for human chemoprevention trials? Gastroenterology (2002) 0.79
Endoanal ultrasound compared to anorectal manometry for the evaluation of fecal incontinence: a study of the effect these tests have on clinical outcome. Dig Dis Sci (2006) 0.79
Endoscopy in the obese patient. Gastroenterol Clin North Am (2010) 0.79
Warm water infusion during sedated colonoscopy does not decrease amount of sedation medication used. Gastrointest Endosc (2012) 0.78
Colonoscopy reports and current state of performance measures. Gastrointest Endosc Clin N Am (2010) 0.78
Pancreatitis before pancreatic cancer: clinical features and influence on outcome. J Clin Gastroenterol (2014) 0.78
Improving ERCP quality and decreasing risk to patients and providers. Expert Rev Gastroenterol Hepatol (2013) 0.78
Role of endoscopic ultrasound in superficial esophageal cancer. Dis Esophagus (2008) 0.78